» Articles » PMID: 10525907

Surgical Intervention in Necrotizing Enterocolitis in Neonates with Symptomatic Congenital Heart Disease

Overview
Date 1999 Oct 20
PMID 10525907
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The commonly accepted indication for surgical intervention in necrotizing enterocolitis (NEC) is perforation of the bowel. In this study, the indication and role of surgery was assessed in neonates born with symptomatic congenital heart disease (CHD). Records of neonates admitted to a single institution in Hong Kong between January 1981 and December 1997 with symptomatic CHD who subsequently developed NEC were reviewed. The patients were categorized into cyanotic and acyanotic groups. Of 850 neonates with CHD admitted during the period, 30 developed NEC (3.5%); 17 had cyanotic and 13 had acyanotic heart disease. The average Apgar scores at 1 and 5 min were 7.5 and 8.6, respectively. The mean gestational age was 37.7 weeks and the mean birth weight was 2.5 kg. The mean age at which NEC developed was 16 days. The overall mortality in the proven cases of NEC was 57%. After excluding the suspected NEC cases (stage I), it was found that surgery in the proven NEC cases without perforation, i.e., stages II and IIIA, resulted in higher survival than in those managed medically (75% vs 44%). The cyanotic patients had higher mortality than the acyanotic group (71% vs 39%). Neonates with CHD who develop NEC belong to a unique group of mature babies with reasonable birth weights and Apgar scores, unlike the common NEC patient population. The mortality of these patients is extremely high, and a modified management approach is required. Surgical intervention may be indicated at a much earlier stage of proven NEC before gut perforation occurs.

Citing Articles

Cardiogenic Necrotizing Enterocolitis in Infants with Congenital Heart Disease: A Systematic Review and Meta-analysis.

Asztalos I, Hill S, Nash D, Schachtner S, Palm K Pediatr Cardiol. 2024; .

PMID: 39467858 DOI: 10.1007/s00246-024-03686-4.


Risk Factors for Adverse Outcomes in Term Infants with CHD and Definitive Necrotising Enterocolitis.

Deitch A, Moynihan K, Przybylski R, Gauvreau K, Braudis N, Farr B Cardiol Young. 2023; 34(1):92-100.

PMID: 37226515 PMC: 11827044. DOI: 10.1017/S104795112300121X.


Clinical Characteristics and Potential Pathogenesis of Cardiac Necrotizing Enterocolitis in Neonates with Congenital Heart Disease: A Narrative Review.

Burge K, Gunasekaran A, Makoni M, Mir A, Burkhart H, Chaaban H J Clin Med. 2022; 11(14).

PMID: 35887751 PMC: 9320426. DOI: 10.3390/jcm11143987.


Necrotizing enterocolitis and congenital heart disease.

Kashif H, Abuelgasim E, Hussain N, Luyt J, Harky A Ann Pediatr Cardiol. 2022; 14(4):507-515.

PMID: 35527771 PMC: 9075549. DOI: 10.4103/apc.apc_30_21.


Primary peritoneal drainage in neonates with necrotizing enterocolitis associated with congenital heart disease: a single experience in a Brazilian tertiary center.

Canesin W, Volpe F, Goncalves-Ferri W, Manso P, Aragon D, Sbragia L Braz J Med Biol Res. 2021; 54(9):e10220.

PMID: 34076139 PMC: 8186373. DOI: 10.1590/1414-431X2020e10220.